Sunesis Pharmaceuticals, Inc.

📍 South San Francisco, United States🗓 Founded 1987👥 42 employees💰 Last funded 2005
Biotechnology Research🌐 sunesis.com
Website LinkedIn
Sunesis is a biopharmaceutical company focused on the development and future commercialization of new oncology therapeutics for the treatment of hematologic and solid tumor cancers. Sunesis has built an experienced cancer drug development organization committed to improving the lives of people with cancer. The company is focused on advancing its novel kinase-inhibitor pipeline, with an emphasis on establishing proof of concept that it's oral non-covalent BTK inhibitor, vecabrutinib (SNS-062), is effective in the treatment of ibrutinib-resistant chronic lymphocytic leukemia. The commitment to advancing oncology treatment and patient care is paramount at Sunesis, and it drives every aspect of our business. • Our work—pursuing the best possible translational and clinical science to ensure that we deliver important new drugs to patients • Our workplace—creating a stimulating, teamwork-oriented environment for our people involved in this important work • Our world—supporting the larger oncology community and the philanthropic organizations that help patients and caregivers
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1987
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Sunesis Pharmaceuticals, Inc.?
Sunesis Pharmaceuticals, Inc. has 1 investors on record on gritt.io.
When did Sunesis Pharmaceuticals, Inc. last raise funding?
The most recent investment in Sunesis Pharmaceuticals, Inc. recorded on gritt.io was in 2005.
When was Sunesis Pharmaceuticals, Inc. founded?
Sunesis Pharmaceuticals, Inc. was founded in 1987.
What industry is Sunesis Pharmaceuticals, Inc. in?
Sunesis Pharmaceuticals, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Sunesis Pharmaceuticals, Inc. based?
Sunesis Pharmaceuticals, Inc. is headquartered in South San Francisco, United States.